Amgen - In the News - Pipeline in the News

In the News

Pipeline in the News


May 16, 2012	Amgen at ASCO 2012
Nov. 26, 2010	Amgen Statement on Briefing Materials Prepared for November 30, 2010 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting
Oct. 28, 2010	Amgen to Participate in Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
Jun. 4, 2010	Amgen at ASCO 2010
Feb. 9, 2010	Denosumab Study Published in the Lancet Oncology Demonstrated Tumor Response for 86 Percent of Patients with Giant Cell Tumor of the Bone
Aug. 11, 2009	Amgen Statement on Posting of Briefing Documents for the Review of Denosumab by the FDA Advisory Committee for Reproductive Health Drugs
May 15, 2009	Amgen Highlights Data to Be Presented at ASCO
Apr. 16, 2009	Preclinical Data from Amgen�s Oncology Pipeline to be Presented at AACR
Sept. 15 , 2008	Amgen Issues the Following Statement in Response to Erroneous News Coverage on Denosumab
Jul. 24 , 2008	Amgen Statement on Business Wire® Erroneous Release of Nplate� (romiplostim) News
Jun. 4 , 2008	Amgen Presents New Data at ASCO
Apr. 21 , 2008	Amgen Issues Statement in Response to Sheffield Telegraph Story on Denosumab
Apr. 8 , 2008	Amgen Statement on Romiplostim PDUFA Date
Apr. 3 , 2008	Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
Apr. 2, 2008	Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
Mar. 12 , 2008	Amgen to Discuss Romiplostim Application at FDA ODAC Meeting
Mar. 10 , 2008	Amgen Statement on Briefing Materials Prepared for March 12, 2008 ODAC Meeting

footer